| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 07/27/2005 | CN1646556A Blanched polyamine steroid derivatives |
| 07/27/2005 | CN1646555A Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 07/27/2005 | CN1646101A Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/26/2005 | US6921757 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 07/26/2005 | CA2171740C 0rally active derivatives of 1,3,5(10)-estratriene |
| 07/21/2005 | US20050159609 Reacting ethinyl estradiol with a linking goup slected from a carbonate, a polyoxyethylene glycol and succinic anhydride, an aliphatic diacid, a peptide linkage having 2-15 amia tert-butoxycarbonyl protected cysteic acidno acids |
| 07/21/2005 | US20050159594 Aldosterone receptor antagonist; comprises 7-methyl hydrogen 4a,5a;9a,11a-diepoxy-17 hydroxy-3-oxo-17a-pregnane-7a,21-dicarboxylate, gamma-lactone as dopant |
| 07/21/2005 | US20050159341 Scaffolded maleimide clusters for multivalent peptide assembly |
| 07/20/2005 | EP1242444B1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 07/13/2005 | EP1551860A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 07/13/2005 | CN1637015A 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations |
| 07/12/2005 | US6916921 Steroid being specifically characterized by amino nitrogen bonded to C17 of the steroid skeleton via a spacer A ( A= substituted or unsubstitued methylene or ethylene group); stimulates meiosis in human oocytes |
| 07/12/2005 | US6916835 Nitrate esters and their use for neurological conditions |
| 06/30/2005 | US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 06/30/2005 | US20050143364 21-Substituted progesterone derivatives as new antiprogestational agents |
| 06/29/2005 | CN1208341C S-substituted 11 & beta-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for production thereof and pharmaceutical preparations containing these compounds |
| 06/28/2005 | CA2138839C Sialic acid derivatives |
| 06/23/2005 | WO2005042422A3 Optical fiber with low pmd and method of making it by spinning |
| 06/23/2005 | US20050137191 Nitrate esters and their use for mitigating cellular damage |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/16/2005 | WO2005054271A1 Assay for ligands of the ecdysone receptor |
| 06/16/2005 | CA2547609A1 Assay for ligands of the ecdysone receptor |
| 06/14/2005 | US6906098 Cycloalkyl-spiro-1, 2,4,5-tetraoxacyclohexane-spiro-cholic acids and derivatives; antiprotozoa agents, bactericides and antitumor agents |
| 06/09/2005 | US20050124643 Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 06/07/2005 | US6903084 Steroid sulphatase inhibitors |
| 06/01/2005 | EP1534733A2 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |
| 06/01/2005 | EP1254179A4 An in vivo screen using chemical inducers of dimerization |
| 05/31/2005 | US6900193 Urogential disorders; antitumor agents; hormone inhibitor |
| 05/26/2005 | WO2005009361A3 Method of treating hit patients with argatroban |
| 05/25/2005 | EP1532159A2 Scaffolded maleimide clusters for multivalent peptide assembly |
| 05/18/2005 | CN1617879A 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/18/2005 | CN1202120C Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 05/17/2005 | CA2057099C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 05/12/2005 | WO2005042422A2 Optical fiber with low pmd and method of making it by spinning |
| 05/12/2005 | US20050101583 Process and intermediates for the production of 7-substituted antiestrogens |
| 05/12/2005 | US20050101573 Meiosis regulating compounds |
| 05/12/2005 | US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 05/11/2005 | EP1210359B1 A process for the preparation of 3-amino bile acid derivatives |
| 05/04/2005 | EP1259532B1 Bile acids conjugates with metal ion chelates and the use thereof |
| 05/03/2005 | US6887991 Converting a 7-cyano substituted steroid to the corresponding 7- carboxylic acid substituted steroid, and thereafter converting the 7-carboxylic acid substituted steroid to the corresponding 5,7-lactone substituted steroid |
| 04/28/2005 | WO2005037851A1 Crystalline forms of 3-beta-amino 17-methylene androstane-6-alpha 7-beta-diol hydrochloride |
| 04/28/2005 | US20050090477 Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom |
| 04/28/2005 | CA2542821A1 Crystalline forms of 3-beta-amino 17-methylene androstane-6-alpha 7-beta-diol hydrochloride |
| 04/27/2005 | EP1525215A1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 04/27/2005 | EP1525182A1 Photoactive materials |
| 04/26/2005 | US6884796 Useful for relieving infertility in females and males |
| 04/26/2005 | CA2123052C Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 04/21/2005 | US20050085556 Generated by atherosclerosis plaque; contacting with antibody; measurement; calibration |
| 04/21/2005 | US20050085426 Acid-sensitive compounds, preparation and use thereof |
| 04/20/2005 | EP1523568A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 04/20/2005 | EP1523302A2 Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/14/2005 | US20050080060 Antigestagenically active steroids with a fluorinated 17alpha-alkyl chain |
| 04/13/2005 | EP1522543A1 Use Steroid sulphatase inhibitors for the manufacture of a medicament for the treatment of an oestrogen dependent tumour |
| 04/07/2005 | WO2005030120A2 Antiangiogenic agents |
| 04/07/2005 | CA2527074A1 Antiangiogenic agents |
| 04/06/2005 | EP1519943A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 04/06/2005 | EP1299409B1 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/06/2005 | EP0663013B1 Method for delivering nucleic acids into cells |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/05/2005 | CA2170286C Synthesis of 17-(3-pyridyl) steroids |
| 03/31/2005 | WO2002042319A9 2-substituted estrogens as antiangiogenic agents |
| 03/31/2005 | US20050069267 Method of making spun optical fiber with low PMD |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517914A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 03/29/2005 | CA2100514C 17-spiromethylene steroids |
| 03/24/2005 | WO2005026190A1 Process for producing cyclic amine |
| 03/24/2005 | US20050064023 Lipid linked to a delivery, targeting or stabilising moiety (DTS moiety) via a linker which is stable in biological fluid and which is unstable in defined conditions, forms a complex with a therapeutic agent; for non-viral gene transfer |
| 03/17/2005 | WO2005023831A1 Detection of cholesterol ozonation products |
| 03/17/2005 | CA2537984A1 Detection of cholesterol ozonation products |
| 03/01/2005 | US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception |
| 02/24/2005 | WO2003090721A3 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations |
| 02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/17/2005 | US20050038029 Transferring, releasing nitric oxide; side effect reduction; using a compound containing nitrosos group |
| 02/15/2005 | CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids |
| 02/10/2005 | US20050032765 Steroid derived antibiotics |
| 02/10/2005 | US20050032764 oximation of d-norgestrel to form d-(17 alpha )-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3E- and -3Z-oxime isomers, used as contraceptives; hormone replacement therapy |
| 02/10/2005 | US20050032763 Process for the synthesis of high purity D-(17a)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one oxime |
| 02/09/2005 | EP1504020A2 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 02/03/2005 | WO2005009361A2 Method of treating hit patients with argatroban |
| 02/03/2005 | WO2004085457A3 17beta-hydroxysteroid dehydrogenase inhibitors |
| 02/03/2005 | US20050026891 Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy |
| 02/03/2005 | US20050026068 Polycarbocyclic derivatives for modification of resist, optical and etch resistance properties |
| 02/02/2005 | CN1187366C New 19-nor-pregene derivatives |
| 02/02/2005 | CN1187365C Use of 9-alpha-hydroxyl-17-methylene steroids in prepn. of corticosteroids |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 01/25/2005 | US6846812 7-Oxo-DHEA compounds for treating keratinous conditions/afflictions |
| 01/20/2005 | US20050014737 Antiangiogenic agents |
| 01/19/2005 | EP1497309A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/19/2005 | EP1497308A1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 01/19/2005 | EP1496865A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 01/13/2005 | US20050009076 Conjugate of hormone (thyroxine) and inosine-5'-monophosphate dehydrogenase inhibitor (such as mycophenolic acid) |
| 01/12/2005 | EP1495042A1 Blanched polyamine steroid derivatives |
| 01/12/2005 | EP1494533A2 Farnesoid x-activated receptor agonists |
| 01/12/2005 | CN1564840A Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display |
| 01/11/2005 | US6841690 Polyazido compounds |
| 01/11/2005 | US6841548 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 01/06/2005 | WO2005000868A1 Process for the synthesis of high purity d-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 01/06/2005 | WO2005000867A1 PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS |